A detailed history of Signaturefd, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Signaturefd, LLC holds 633 shares of UTHR stock, worth $222,290. This represents 0.0% of its overall portfolio holdings.

Number of Shares
633
Previous 582 8.76%
Holding current value
$222,290
Previous $185,000 22.16%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$311.04 - $363.55 $15,863 - $18,541
51 Added 8.76%
633 $226,000
Q2 2024

Jul 29, 2024

BUY
$228.26 - $319.04 $24,880 - $34,775
109 Added 23.04%
582 $185,000
Q1 2024

May 03, 2024

BUY
$210.76 - $249.51 $13,488 - $15,968
64 Added 15.65%
473 $108,000
Q4 2023

Jan 31, 2024

BUY
$214.88 - $256.94 $3,223 - $3,854
15 Added 3.81%
409 $89,000
Q3 2023

Nov 03, 2023

BUY
$211.82 - $248.24 $4,236 - $4,964
20 Added 5.35%
394 $88,000
Q2 2023

Aug 01, 2023

SELL
$205.19 - $232.99 $7,386 - $8,387
-36 Reduced 8.78%
374 $82,000
Q1 2023

Apr 28, 2023

BUY
$212.99 - $276.17 $14,696 - $19,055
69 Added 20.23%
410 $91,000
Q4 2022

Jan 27, 2023

SELL
$205.95 - $280.43 $6,384 - $8,693
-31 Reduced 8.33%
341 $94,000
Q3 2022

Nov 08, 2022

BUY
$203.3 - $244.17 $1,016 - $1,220
5 Added 1.36%
372 $78,000
Q2 2022

Aug 10, 2022

BUY
$174.81 - $241.14 $1,573 - $2,170
9 Added 2.51%
367 $86,000
Q1 2022

May 02, 2022

SELL
$166.16 - $213.96 $11,132 - $14,335
-67 Reduced 15.76%
358 $64,000
Q4 2021

Jan 25, 2022

BUY
$184.32 - $216.08 $7,372 - $8,643
40 Added 10.39%
425 $92,000
Q3 2021

Oct 28, 2021

BUY
$179.86 - $214.88 $2,877 - $3,438
16 Added 4.34%
385 $71,000
Q2 2021

Jul 26, 2021

BUY
$170.47 - $211.93 $1,193 - $1,483
7 Added 1.93%
369 $66,000
Q1 2021

Apr 30, 2021

BUY
$153.94 - $174.85 $8,312 - $9,441
54 Added 17.53%
362 $61,000
Q4 2020

Feb 11, 2021

BUY
$101.87 - $151.79 $11,001 - $16,393
108 Added 54.0%
308 $47,000
Q3 2020

Nov 03, 2020

SELL
$99.9 - $121.13 $12,087 - $14,656
-121 Reduced 37.69%
200 $20,000
Q2 2020

Jul 30, 2020

BUY
$92.74 - $125.82 $17,342 - $23,528
187 Added 139.55%
321 $39,000
Q1 2020

Apr 23, 2020

BUY
$79.39 - $115.35 $1,984 - $2,883
25 Added 22.94%
134 $13,000
Q4 2019

Feb 05, 2020

BUY
$78.31 - $95.34 $2,505 - $3,050
32 Added 41.56%
109 $10,000
Q3 2019

Oct 16, 2019

BUY
$74.85 - $85.99 $74 - $85
1 Added 1.32%
77 $6,000
Q2 2019

Jul 31, 2019

SELL
$76.06 - $120.81 $54,915 - $87,224
-722 Reduced 90.48%
76 $6,000
Q1 2019

May 09, 2019

BUY
$107.15 - $126.84 $25,287 - $29,934
236 Added 41.99%
798 $94,000
Q4 2018

Feb 13, 2019

SELL
$101.4 - $128.73 $49,686 - $63,077
-490 Reduced 46.58%
562 $61,000
Q3 2018

Nov 15, 2018

BUY
$113.81 - $129.46 $27,655 - $31,458
243 Added 30.04%
1,052 $135,000
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $7,079 - $8,281
70 Added 9.47%
809 $92,000
Q1 2018

May 08, 2018

BUY
$107.21 - $151.94 $79,228 - $112,283
739 New
739 $83,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.